KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Progyny (PGNY) Enterprise Value (2018 - 2025)

Historic Enterprise Value for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to -$345.2 million.

  • Progyny's Enterprise Value fell 4644.79% to -$345.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$345.2 million, marking a year-over-year decrease of 4644.79%. This contributed to the annual value of -$228.0 million for FY2024, which is 3857.13% up from last year.
  • Progyny's Enterprise Value amounted to -$345.2 million in Q3 2025, which was down 4644.79% from -$305.1 million recorded in Q2 2025.
  • Progyny's Enterprise Value's 5-year high stood at -$94.0 million during Q2 2021, with a 5-year trough of -$371.8 million in Q1 2024.
  • Over the past 5 years, Progyny's median Enterprise Value value was -$228.0 million (recorded in 2024), while the average stood at -$220.7 million.
  • In the last 5 years, Progyny's Enterprise Value tumbled by 13799.2% in 2023 and then soared by 3857.13% in 2024.
  • Over the past 5 years, Progyny's Enterprise Value (Quarter) stood at -$119.4 million in 2021, then crashed by 58.52% to -$189.3 million in 2022, then crashed by 96.03% to -$371.1 million in 2023, then surged by 38.57% to -$228.0 million in 2024, then plummeted by 51.44% to -$345.2 million in 2025.
  • Its Enterprise Value stands at -$345.2 million for Q3 2025, versus -$305.1 million for Q2 2025 and -$256.1 million for Q1 2025.